December 12, 2024
The clinical and cost impact of MSK-linked depression
Depression and MSK pain often go hand-in-hand — but are rarely treated together. This report explores how Sword’s integrated model improves outcomes and reduces total cost of care.
Depression and chronic pain fuel one another — and when left unaddressed together, they lead to worse outcomes and higher costs. This whitepaper outlines the link between MSK and mental health, shares data from Sword’s dual-approach solution, and quantifies how integrated care improves outcomes and reduces opioid use, surgery intent, and total MSK spend.
52%
decrease in depression
48%
reduction in opioid use
65%
drop in surgery intent
34%
MSK-related cost savings
Download the report to see how integrated care for MSK pain and mental health drives clinical and financial ROI.
Contributors to White Paper
Sword Team
Experts in pain, movement, and digital health
